No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Dr. Kimberley Dilts and Dylan Griswold: New Team Members of MicroCare

Editor: What To Know

  • She brings a wealth of experience to the role and will ensure that MicroCare fully observes all local, regional and global regulations to make certain that all information, including data sheets and labels, are always up to date and compliant.
  • “With his talent and enthusiasm, he will fulfil the role perfectly and help to manage the purchasing and material planning for our global production and operations.
  • I'm excited to begin this new chapter and I look forward to our future together at MicroCare.

April 8, 2021

Dr. Kimberley Dilts has joined MicroCare as the Global Regulatory Manager and Mr. Dylan Griswold has joined as Senior Sourcing Analyst.

Dr. Kimberley Dilts is responsible for assuring the MicroCare portfolio of products comply with global chemical control legislation.  With a Ph.D. in Chemistry and extensive knowledge of GHS (Globally Harmonized System) classifications, Dr. Dilts is experienced in managing ongoing chemical compliance and worldwide regulations which continue to require regular updates.

Emily Peck, MicroCare Senior Chemist said: “We are delighted to welcome Dr. Dilts to MicroCare. She brings a wealth of experience to the role and will ensure that MicroCare fully observes all local, regional and global regulations to make certain that all information, including data sheets and labels, are always up to date and compliant. She is a great asset to the company.”

Dr. Dilts added: “I’m happy to be joining the MicroCare team and I’m looking forward to helping the company grow.”

Dylan Griswold To further enhance to our in-house expertise, MicroCare welcomes Mr. Dylan Griswold to the sourcing and procurement team. Having held a similar post as a buyer at Savage Arms, Inc. for nearly 6 years, Mr. Griswold is responsible for overseeing vendor relationships and improving the supply chain operations of the business.

“We are very pleased to have Dylan on board,” said Jim Gluck, MicroCare Senior Procurement Manager. “With his talent and enthusiasm, he will fulfil the role perfectly and help to manage the purchasing and material planning for our global production and operations.”

Mr. Griswold added: “The team at MicroCare has provided me with a warm welcome to the company. I’m excited to begin this new chapter and I look forward to our future together at MicroCare!”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy